Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Rivero-Juarez, A; Frias, M; Lopez-Lopez, P; Berenguer, J; Garcia, F; Macias, J; Alcaraz, B; Castro-Iglesias, A; Caballero-Gomez, J; Rivero, A; CoRIS Cohort.

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain

Frontiers in Microbiology. 2020; 11: Nº de citas: 12 [doi:10.3389/fmicb.2020.564486]

Bastos-Oreiro, M; Balsalobre, P; Miralles, P; Berenguer, J; Dorado, N; Bailen, R; Obreoscoa, G; Anguita, J; Serrano, D; Diez-Martin, JL; Kwon, M.

Autologous stem cell transplantation for lymphoma in HIV plus patients: higher rate of infections compared with non-HIV lymphoma

BONE MARROW TRANSPLANTATION. 2020; 55(9): 1716-1725 Nº de citas: 6 [doi:10.1038/s41409-020-0846-0]

Salguero, S; Rojo, D; Berenguer, J; Gonzalez-Garcia, J; Fernandez-Rodriguez, A; Brochado-Kith, O; Diez, C; Hontanon, V; Virseda-Berdices, A; Martinez, J; Ibanez-Samaniego, L; Llop-Herrera, E; Barbas, C; Resino, S; Jimenez-Sousa, MA.

Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients

LIVER INTERNATIONAL. 2020; 40(9): 2215-2227 Nº de citas: 8 [doi:10.1111/liv.14580]

Carrasco, I; Sainz, T; Frick, MA; de Ory, SJ; Fortuny, C; Burgos, J; Montero, M; Gavilan, C; Falcon, MD; Couceiro, JA; Bernardino, JI; Bisbal, O; Guerrero, C; Aldamiz-Echevarria, MT; Berenguer, J; Navarro, ML.

Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients

JOURNAL OF VIRAL HEPATITIS. 2020; 27(9): 955-958 Nº de citas: 8 [doi:10.1111/jvh.13308]

Lopez-Centeno, B; Badenes-Olmedo, C; Mataix-Sanjuan, A; Bellon, JM; Perez-Latorre, L; Lopez, JC; Benedi, J; Khoo, S; Marzolini, C; Calvo-Alcantara, MJ; Berenguer, J.

Potentially inappropriate medications in older adults living with HIV

HIV MEDICINE. 2020; 21(8): 541-546 Nº de citas: 11 [doi:10.1111/hiv.12883]

Molina-Carrion, S; Brochado-Kith, S; Gonzalez-Garcia, J; Berenguer, J; Diez, C; Llop, E; Hontanon, V; Ibanez-Samaniego, L; Montes, ML; Resino, S; Fernandez-Rodriguez, A; Jimenez-Sousa, MA.

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals

Journal of Clinical Medicine. 2020; 9(8): Nº de citas: 7 [doi:10.3390/jcm9082407]

Garcia, M; Lopez-Fernandez, L; Minguez, P; Moron-Lopez, S; Restrepo, C; Navarrete-Munoz, MA; Lopez-Bernaldo, JC; Benguria, A; Garcia, MI; Cabello, A; Fernandez-Guerrero, M; De la Hera, FJ; Estrada, V; Barros, C; Martinez-Picado, J; Gorgolas, M; Benito, JM; Rallon, N.

Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control

JOURNAL OF MOLECULAR MEDICINE-JMM. 2020; 98(8): 1093-1105 Nº de citas: 6 [doi:10.1007/s00109-020-01930-x]

Berenguer, J; Parrondo, J; Landovitz, RJ.

Quantifying the reduction in sexual transmission of HIV-1 among MSM by early initiation of ART: A mathematical model

PLoS One. 2020; 15(7): Nº de citas: 3 [doi:10.1371/journal.pone.0236032]

Lopez-Centeno, B; Badenes-Olmedo, C; Mataix-Sanjuan, A; McAllister, K; Bellon, JM; Gibbons, S; Balsalobre, P; Perez-Latorre, L; Benedi, J; Marzolini, C; Aranguren-Oyarzabal, A; Khoo, S; Calvo-Alcantara, MJ; Berenguer, J.

Polypharmacy and Drug-Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study

CLINICAL INFECTIOUS DISEASES. 2020; 71(2): 353-362 Nº de citas: 58 [doi:10.1093/cid/ciz811]

Salguero, S; Medrano, LM; Gonzalez-Garcia, J; Berenguer, J; Montes, ML; Diez, C; Garcia-Broncano, P; Llop-Herrera, E; Perez-Latorre, L; Bellono, JM; Jimenez-Sousa, MA; Resino, S.

Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study

Scientific Reports. 2020; 10(1): Nº de citas: 7 [doi:10.1038/s41598-020-67159-3]

Alvaro-Meca, A; Mate-Cano, I; Ryan, P; Briz, V; Resino, S.

Epidemiological Trend of Sepsis in Patients with Hospital Admissions Related to Hepatitis C in Spain (2000-2015): A Nationwide Study

Journal of Clinical Medicine. 2020; 9(6): Nº de citas: 3 [doi:10.3390/jcm9061607]

Trickey, A; May, MT; Gill, MJ; Grabar, S; Vehreschild, J; Wit, FWNM; Bonnet, F; Cavassini, M; Abgrall, S; Berenguer, J; Wyen, C; Reiss, P; Grabmeier-Pfistershammer, K; Guest, JL; Shepherd, L; Teira, R; Monforte, AD; del Amo, J; Justice, A; Costagliola, D; Sterne, JAC.

Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies

INTERNATIONAL JOURNAL OF CANCER. 2020; 146(11): 3134-3146 Nº de citas: 13 [doi:10.1002/ijc.32895]

Mate-Cano, I; Alvaro-Meca, A; Ryan, P; Resino, S; Briz, V.

Epidemiological trend of hepatitis C-related liver events in Spain (2000-2015): A nationwide population-based study

EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2020; 75: 84-92 Nº de citas: 8 [doi:10.1016/j.ejim.2020.02.002]

Casado, JL; Vizcarra, P; Blanco, JL; Montejano, R; Negredo, E; Espinosa, N; Montero, M; Mena, A; Palacios, R; Lopez, JC; Vergas, J; Galindo, MJ; Cabello, A; Deltoro, MG; De Santiago, AD.

Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients

INTERNATIONAL JOURNAL OF STD & AIDS. 2020; 31(5): 467-473 Nº de citas: 4 [doi:10.1177/0956462419896478]

Valencia, J; Alvaro-Meca, A; Troya, J; Gutierrez, J; Ramon, C; Rodriguez, A; Vazquez-Moron, S; Resino, S; Moreno, S; Ryan, P.

Gender-based vulnerability in women who inject drugs in a harm reduction setting

PLoS One. 2020; 15(3): Nº de citas: 28 [doi:10.1371/journal.pone.0230886]

Alvarez, S; Branas, F; Sanchez-Conde, M; Moreno, S; de Quiros, JCLB; Munoz-Fernandez, MA.

Frailty, markers of immune activation and oxidative stress in HIV infected elderly

PLoS One. 2020; 15(3): Nº de citas: 26 [doi:10.1371/journal.pone.0230339]

Vizcarra, P; Blanco, JL; Montejano, R; Negredo, E; Espinosa, N; Casado, JL; Monsalvo, M; Blanco, JL; Bernardino, JI; Puig, J; Montero, M; Castro, I; Mena, A; Castro, A; Palacios, R; de Quiros, JCLB; Tejerina, F; Latorre, LP; Ramirez, M; Vergas, J; Tellez, MJ; Galindo, P; Vilalta, RF; Cabello, A; Deltoro, MG; Cuevas, PR; de Santiago, AD; Moral, SD.

Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy

INFECTIOUS DISEASES. 2020; 52(3): 202-206 Nº de citas: 3 [doi:10.1080/23744235.2019.1694696]

Hernandez-Walias, FJ; Vazquez, E; Pacheco, Y; Rodriguez-Fernandez, JM; Perez-Elias, MJ; Dronda, F; Casado, JL; Moreno, A; Hermida, JM; Quereda, C; Hernando, A; Tejerina-Picado, F; Asensi, V; Galindo, MJ; Leal, M; Moreno, S; Vallejo, A.

Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21

Journal of Clinical Medicine. 2020; 9(3): Nº de citas: 13 [doi:10.3390/jcm9030760]